News Image

Which stocks are moving before the opening bell on Wednesday?

By Mill Chart

Last update: Sep 28, 2022

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.

Gainers

TickerChangeComment
PRTA59.39%PROTHENA CORP PLC's (NASDAQ:PRTA) shares rose 59.39% to $49.3. In the last 6 months the share price dropped with 20.81%.
BIIB53.95%BIOGEN INC's (NASDAQ:BIIB) stock price is advancing with 53.95% to a price of $304.5. The stock is trading 30.34% lower than a year ago.
LGVN27.79%LONGEVERON INC's (NASDAQ:LGVN) shares rose 27.79% to $5.15. In the last month the stock lost 24.11%.
BNTC18.92%BENITEC BIOPHARMA INC's (NASDAQ:BNTC) shares rose 18.92% to $0.38 during Wednesday's pre-market session. In the last month the stock lost 55.44%.
NNOX16.42%NANO-X IMAGING LTD's (NASDAQ:NNOX) shares rose 16.42% to $11.84. The stock is trading 23.36% lower than a month ago.
EFOI15.05%ENERGY FOCUS INC (NASDAQ:EFOI) rose 15.05% to $0.61 during Wednesday's pre-market session. The stock is trading 29.77% lower than a month ago.
BIVI14.4%BIOVIE INC's (NASDAQ:BIVI) shares rose 14.4% to $2.7 during Wednesday's pre-market session. In the last month the stock lost 26.48%.
TENX14.34%TENAX THERAPEUTICS INC (NASDAQ:TENX) rose 14.34% to $0.19 during Wednesday's pre-market session. The stock is trading 32.08% lower than a month ago.
IGC14.0%INDIA GLOBALIZATION CAPITAL's (NYSEARCA:IGC) shares rose 14.0% to $0.48. In the last month the share price dropped with 23.84%.
ELYS13.94%ELYS GAME TECHNOLOGY CORP's (NASDAQ:ELYS) shares rose 13.94% to $0.53 during Wednesday's pre-market session. In the last 3 months the stock lost 30.16%.

For the full premarket gainers list go to our premarket gainers screener.

Pre-market losers

TickerChangeComment
MNMD-38.07%MIND MEDICINE MINDMED INC's (NASDAQ:MNMD) shares fell 38.07% to $3.79 during Wednesday's pre-market session. In the last month the share price dropped with 49.04%.
PHAS-36.84%PHASEBIO PHARMACEUTICALS INC's (NASDAQ:PHAS) shares fell 36.84% to $0.48 during Wednesday's pre-market session. In the last month the stock lost 32.74%.
IBIO-33.58%IBIO INC's (NYSEARCA:IBIO) shares fell 33.58% to $0.21 during Wednesday's pre-market session. In the last 3 months the share price increased with 21.54%.
LTRYW-28.79%LOTTERY.COM -CW21's (NASDAQ:LTRYW) stock price is declining with 28.79% to a price of $0.01. In the last month the share price dropped with 37.93%.
NA-27.67%NANO LABS LTD-ADR's (NASDAQ:NA) shares fell 27.67% to $2.3. NASDAQ:NA already had a hard day yesterday: closing -15.83% lower during the regular session. Yesterday the company had a press release: Nano Labs Ltd Announces Pricing of Public Offering of American Depositary Shares.
ATXI-18.18%AVENUE THERAPEUTICS INC's (NASDAQ:ATXI) shares fell 18.18% to $5.94 during Wednesday's pre-market session. After yesterdays gain of 106.0%, it goes down with 18.18% in today's pre-market session.
GMDA-17.86%GAMIDA CELL LTD's (NASDAQ:GMDA) shares fell 17.86% to $1.61 during Wednesday's pre-market session. A press release (Gamida Cell Announces Entry into Commitment Letter with Highbridge for $25 Million Financing) was released yesterday.
PBTS-11.5%POWERBRIDGE TECHNOLOGIES CO's (NASDAQ:PBTS) shares fell 11.5% to $0.53. After running up 19.31% in yesterday's session, NASDAQ:PBTS is pulling back pre-market.
CGNT-11.36%COGNYTE SOFTWARE LTD's (NASDAQ:CGNT) stock price is declining with 11.36% to a price of $3.9. The company's earnings where released Yesterday. Earlier today the company had a press release: Cognyte Announces Second Quarter Results.
FHS-10.96%FIRST HIGH-SCHOOL EDUCAT-ADR's (NYSE:FHS) shares fell 10.96% to $0.65. In the last 6 months the stock lost 51.97%.

For the full premarket loser list go to our premarket losers screener.

Back

AVENUE THERAPEUTICS INC

NASDAQ:ATXI (4/24/2024, 7:48:12 PM)

After market: 0.093 0 (-1.38%)

0.0943

-0.04 (-29.63%)

ATXI News

News Image6 hours ago - ChartmillTop movers in Wednesday's session

Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.

News Image11 hours ago - ChartmillTraders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.

News Image14 hours ago - Avenue TherapeuticsAvenue Therapeutics Announces Reverse Stock Split

MIAMI, April 24, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...

News Image15 days ago - ChartmillTop movers in Tuesday's after hours session

Get insights into the top gainers and losers of Tuesday's after-hours session.

News Imagea month ago - Avenue TherapeuticsAvenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024

MIAMI, March 25, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...

News Imagea month ago - BusinessInsiderATXI Stock Earnings: Avenue Therapeutics Beats EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Avenue Therapeutics (NASDAQ:ATXI) just reported results for the fourth quarter ...

News Imagea month ago - InvestorPlaceATXI Stock Earnings: Avenue Therapeutics Beats EPS for Q4 2023

ATXI stock results show that Avenue Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

News Imagea month ago - Avenue TherapeuticsAvenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights

- Enrollment completed in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy; topline data expected in second quarter of 2024 - ...

News Imagea month ago - Avenue TherapeuticsAvenue Therapeutics Receives Positive Listing Determination from Nasdaq

MIAMI, March 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...

News Imagea month ago - Avenue TherapeuticsAvenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting

BAER-101 demonstrated full suppression of seizure activity in SynapCell's GAERS model of absence epilepsy, a proven indicator of efficacy in anti-seizure...

News Image2 months ago - Avenue TherapeuticsAvenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy

-In vivo data supports BAER-101’s unique ability to significantly suppress seizures using the SynapCell's Genetic Absence Epilepsy Rat from Strasbourg...

News Image3 months ago - Avenue TherapeuticsAvenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

MIAMI, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused...

ATXI Links
Follow us for more